Prognostic relevance of c-MYC gene amplification and polysomy for chromosome 8 in suboptimally-resected, advanced stage epithelial ovarian cancers: A Gynecologic Oncology Group study
- 1 September 2009
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 114 (3) , 472-479
Abstract
No abstract availableKeywords
This publication has 82 references indexed in Scilit:
- Cancer Statistics, 2008CA: A Cancer Journal for Clinicians, 2008
- HIF and c-Myc: Sibling Rivals for Control of Cancer Cell Metabolism and ProliferationCancer Cell, 2007
- MYC amplification in breast cancer: a chromogenic in situ hybridisation studyJournal of Clinical Pathology, 2006
- Balance of Yin and Yang: Ubiquitylation-Mediated Regulation of p53 and c-MycNeoplasia, 2006
- HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancerJournal of Clinical Pathology, 2006
- Correlations between c-myc gene copy-number and clinicopathological parameters of ovarian tumoursEuropean Journal of Cancer, 2006
- Cancer therapeutics: Targeting the dark side of MycEuropean Journal of Cancer, 2005
- Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian CancerNew England Journal of Medicine, 1996
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- On the Interpretation of χ 2 from Contingency Tables, and the Calculation of PJournal of the Royal Statistical Society, 1922